Hot Features
Premium
Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Período:
Tipo de Línea:
| Volume | 71,794 |
|
|||||
| Noticias | - |
| Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
|---|---|---|---|
| TC BioPharm Holdings PLC | TCBP | NASDAQ | Certificado de Depósito |
| Variación del Día (ptos.) | Variación del Día (%) | Último Precio | Hora
|
|
|---|---|---|---|---|
| -0.04 | -2.55% | 1.53 | 18:56:12 |
| Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
|---|---|---|---|---|
| 1.58 | 1.51 | 1.63 | 1.53 | 1.57 |
| Operaciones | Volume Operado de la Acción | Precio Promedio Ponderado | Volume Financiero | Volumen promedio |
|---|---|---|---|---|
| 405 | 71,794 | 1.55 | 111,571 | - |
| Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
|---|---|---|---|---|
| 18:36:56 | 91 | 1.57 | USD |
Información Financiera TC BioPharm Holdings PLC TCBP
| Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
|---|---|---|---|---|---|---|
| 1.45M | 950.00k | - | 3.85M | -1.39M | -1.46 | - |
| Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
|---|---|---|---|---|---|
| - | - | - | - |
Noticias sobre TC BioPharm Holdings PLC TCBP
| Fecha | Hora | Fuente | Noticia |
|---|---|---|---|
| 04/4/2024 | 07:32 | PR Newswire (US) | TCBP Announces Execution of Non-Binding Letter of Intent for.. |
| 02/4/2024 | 07:30 | PR Newswire (US) | TCBP Increasing Treatment Capacity with Expanded.. |
| 19/3/2024 | 07:30 | PR Newswire (US) | TCBP Adjourns General Meeting Until a Later Date |
| 18/3/2024 | 07:30 | PR Newswire (US) | TCBP Announces Exercise of Series D Warrants For Cash |
| 06/3/2024 | 05:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 01/3/2024 | 07:30 | PR Newswire (US) | Bryan Kobel, CEO of TCBP, Appears on Nationally Syndicated.. |
| 27/2/2024 | 16:15 | PR Newswire (US) | /C O R R E C T I O N -- TC BioPharm/ |
| 27/2/2024 | 07:30 | PR Newswire (US) | TCBP Announces Shareholder Update Call on March 5th 2024 |
| 22/2/2024 | 08:32 | PR Newswire (US) | TCBP Announces MHRA Acceptance of Amendment for ACHIEVE UK.. |
| 20/2/2024 | 05:05 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements |
| 15/2/2024 | 07:30 | PR Newswire (US) | TC BioPharm Management to Participate at Upcoming 7th.. |
| 14/2/2024 | 13:48 | Edgar (US Regulatory) | Form 8-K - Current report |
Histórico TCBP
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Year | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 5 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
